Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Shinde

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
Circulation Research|January 26, 2013
Store-independent Orai1/3 channels activated by intracrine leukotriene C4: role in neointimal hyperplasiaJosé C González-Cobos, Xuexin Zhang, Wei Zhang, et al.
Hepatology (Baltimore, Md.)|March 5, 2019
ReplyKristina Behnke, Yuan Zhuang, Haifeng C Xu, et al.
Hepatology (Baltimore, Md.)|May 10, 2018
B Cell-Mediated Maintenance of Cluster of Differentiation 169-Positive Cells Is Critical for Liver RegenerationKristina Behnke, Yuan Zhuang, Haifeng C Xu, et al.
Gut|August 15, 2019
Fragile X mental retardation protein protects against tumour necrosis factor-mediated cell death and liver injuryYuan Zhuang, Haifeng C Xu, Prashant V Shinde, et al.
Nature Immunology|March 8, 2016
Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infectionMarc Beyer, Zeinab Abdullah, Jens M Chemnitz, et al.
The Indian Journal of Medical Research|March 22, 2024
Neutralizing antibody responses to SARS-CoV-2 Omicron variants: Post six months following two-dose & three-dose vaccination of ChAdOx1 nCoV-19 or BBV152Pragya D Yadav, Viren Sardana, Gururaj Rao Deshpande, et al.
Nature Immunology|July 5, 2020
Publisher Correction: Tumor-necrosis factor impairs CD4<sup>+</sup> T cell-mediated immunological control in chronic viral infectionMarc Beyer, Zeinab Abdullah, Jens M Chemnitz, et al.
Science Signaling|October 31, 2019
iRhom2 inhibits bile duct obstruction-induced liver fibrosisBalamurugan Sundaram, Kristina Behnke, Andrea Belancic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2018
The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in CanadaM K Nichols, M K Andrew, L Ye, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 15, 2014
Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014Sa McNeil, V Shinde, M Andrew, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Circulation Research|January 26, 2013
Store-independent Orai1/3 channels activated by intracrine leukotriene C4: role in neointimal hyperplasiaJosé C González-Cobos, Xuexin Zhang, Wei Zhang, et al.
Hepatology (Baltimore, Md.)|March 5, 2019
ReplyKristina Behnke, Yuan Zhuang, Haifeng C Xu, et al.
Hepatology (Baltimore, Md.)|May 10, 2018
B Cell-Mediated Maintenance of Cluster of Differentiation 169-Positive Cells Is Critical for Liver RegenerationKristina Behnke, Yuan Zhuang, Haifeng C Xu, et al.
Gut|August 15, 2019
Fragile X mental retardation protein protects against tumour necrosis factor-mediated cell death and liver injuryYuan Zhuang, Haifeng C Xu, Prashant V Shinde, et al.
Nature Immunology|March 8, 2016
Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infectionMarc Beyer, Zeinab Abdullah, Jens M Chemnitz, et al.
The Indian Journal of Medical Research|March 22, 2024
Neutralizing antibody responses to SARS-CoV-2 Omicron variants: Post six months following two-dose & three-dose vaccination of ChAdOx1 nCoV-19 or BBV152Pragya D Yadav, Viren Sardana, Gururaj Rao Deshpande, et al.
Nature Immunology|July 5, 2020
Publisher Correction: Tumor-necrosis factor impairs CD4<sup>+</sup> T cell-mediated immunological control in chronic viral infectionMarc Beyer, Zeinab Abdullah, Jens M Chemnitz, et al.
Science Signaling|October 31, 2019
iRhom2 inhibits bile duct obstruction-induced liver fibrosisBalamurugan Sundaram, Kristina Behnke, Andrea Belancic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2018
The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in CanadaM K Nichols, M K Andrew, L Ye, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 15, 2014
Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014Sa McNeil, V Shinde, M Andrew, et al.
Pageof 16